Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs.

George E NaoumZeng B ZhuDonald J BuchsbaumDavid T CurielWaleed O Arafat

Published in: Clinical and translational medicine (2017)

Survivin is a selective potent radiation inducible promoter for glioblastoma viral gene therapy and this response to radiation could be independent of CArG motifs.

Keyphrases

gene therapy
dna methylation
sars cov
transcription factor
gene expression
radiation induced
radiation therapy